新股消息 | 鸿基创能港股IPO招股书失效

Group 1 - The company, Hongji Chuangneng Technology, submitted its Hong Kong IPO prospectus on June 27, which became invalid after six months on December 27, with Haitong International and CITIC Securities as joint sponsors [1] - According to the prospectus, the company claims to be a global leader in independent membrane electrode supply, focusing on the R&D, mass production, and commercialization of catalyst-coated membranes (CCM) and membrane electrode assemblies (MEA) [2] - Based on data from Zhi Shi Consulting, Hongji Chuangneng is projected to be the largest independent membrane electrode supplier in China and the second largest globally by sales volume in 2024 [2]